You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 2
  • P01.01 A Phase 1a/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors

Article metrics

Article menu

Download PDFPDF

E-Poster Presentations
P01 Emerging concepts/novel agents
P01.01 A Phase 1a/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors
Free

 

Online download statistics by month:

Online download statistics by month: October 2020 to September 2024

AbstractFullPdf
Oct 202093020
Nov 20206805
Dec 20203608
Jan 202164012
Feb 20211607
Mar 20217409
Apr 202138011
May 202129012
Jun 2021003
Jul 2021007
Aug 2021008
Sep 2021004
Oct 202130025
Nov 202148017
Dec 20213606
Jan 20222003
Feb 20222603
Mar 20222002
Apr 20224408
May 202252012
Jun 20222805
Jul 20222803
Aug 20221804
Sep 202220010
Oct 20221003
Nov 20221005
Dec 20221801
Jan 20231804
Feb 20233202
Mar 20231801
Apr 2023403
May 20231201
Jun 20231803
Jul 20233805
Aug 20231001
Sep 2023804
Oct 20232202
Nov 20231608
Dec 20234404
Jan 20241200
Feb 20242204
Mar 202424042
Apr 20241206
May 20241206
Jun 20243803
Jul 20242404
Aug 20241403
Sep 20243203
Total12560322